Clinical Trial

855303-RNA Biomarker Validation

Name: 855303-RNA Biomarker Validation — clinical trial record (NCT06872775)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: 855303-RNAVal

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

The purpose of this study is to test the accuracy of using RNA in blood as a way to forecast new fracture healing outcome.

Protocol Amendment History 6 amendments

This ClinicalTrials.gov record has been amended 6 times since 2025-03-10; most recent amendment 2026-01-14.

Trial Details

NCT Number	NCT06872775
Lead Sponsor	University of Pennsylvania Collaborators: PharPoint Research, Inc., Children's Hospital of Philadelphia, Cooperative Human Tissue Network - Eastern Division (CHTN-ED), Osetomics, LLC, Resonant Clinical/Therapak, Claremont, California, ResearchDx, Irvine, CA
Conditions	Fractures, Bone
Enrollment	110 participants
Start Date	2025-08-25
Primary Completion	2028-08-24 (estimated)
Study Completion	2028-08-24 (estimated)
Updated on ClinicalTrials.gov	2026-01-16